Additionally, leptin have been suggested as part of the mechanisms involved in the development of obesity-related carcinogenesis in pancreatic [164], prostate [165] and colorectal cancer [166]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.